Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer ...Middle East

PR Newswire - News
Nanoform Finland Plc April 9, 2024 09.00 EEST / 08.00 CEST HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced a collaboration with PlusVitech, a biotechnology company developing treatments for cancer, to...

Hence then, the article about nanoform and plusvitech partner to repurpose aprepitant as a treatment for lung cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News